Filing Details
- Accession Number:
- 0001214659-20-002747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-18 16:45:42
- Reporting Period:
- 2020-03-16
- Accepted Time:
- 2020-03-18 16:45:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1398733 | Aquestive Therapeutics Inc. | AQST | Pharmaceutical Preparations (2834) | 208623253 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1752955 | J Lori Braender | C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059 | Svp, General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-16 | 14,000 | $1.54 | 25,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2020-03-16 | 60,000 | $0.00 | 60,000 | $1.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
60,000 | 2030-03-16 | No | 4 | A | Direct |
Footnotes
- This transaction was executed in multiple transactions with prices ranging from $1.46 to $1.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.